Cytophage Technologies Inc.
Cytophage is advancing the field of bacteriophage research by implementing synthetic biology techniques to tackle today’s bacterial problems. The World Health Organization predicts that antimicrobial resistance (AMR) to currently available antibiotics will be the leading cause of death in humans by 2050. There is also a growing, worldwide initiative to remove antibiotics from our food systems. Cytophage is uniquely positioned to develop solutions to the world’s AMR issues using our tailor-made bacteriophages.